News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/29/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015

News from Around the Web
Nixing Latex: Building The Perfect Condom With Hydrogel, Plant-Based Antioxidants, Texas A&M University Study     12/1/2015
Charlie Sheen Has HIV. Five Things You Might Not Know About The Virus     11/18/2015
Daily Pills Protect People Against HIV, Whitman-Walker Clinic Study Finds     11/17/2015
Powerful Plastic Microscope Brings Better Diagnostic Care For World's Rural Poor, Rice University Reveals     10/21/2015
Fat-Coated Drugs Keep Immune Cells Free Of HIV, University of Rochester Study     10/20/2015
Science Won't Stop Until It Beats AIDS, Says HIV Pioneer     10/9/2015
Detecting HIV Diagnostic Antibodies With DNA Nanomachines, University Of Montreal Study     10/9/2015
Vaginal Microbes Species Traps HIV, May Be A Biological Condom Someday, University of North Carolina Study     10/8/2015
WHO Ramps Up HIV Drug Push With Call For Early Treatment For All     9/30/2015
Silicone Vaginal Rings To Deliver Antiviral Drugs, Protect Women Against HIV, University Jean Monnet Of Saint-Etienne Study     9/22/2015
International Team Discovers Natural Defense Against HIV, Michigan State University Study     9/16/2015
Encouraging Results From Real-World Users Of Gilead (GILD)'s HIV-Prevention Pill Truvada     9/14/2015
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
Teen's HIV In Remission Despite Stopping Treatment As A Child, Pasteur Institute Reveals     7/21/2015
$4 Million Boost To Turn The Tide On AIDS In Cuyahoga County     7/7/2015

Press Releases
Sangamo BioSciences (SGMO) Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference     2/5/2016
Gilead (GILD) Announces Fourth Quarter And Full Year 2015 Financial Results     2/3/2016
European Medicines Agency Validates Gilead (GILD)’s Type II Variation Application For Truvada® For Reducing The Risk Of Sexually Acquired HIV     2/1/2016
European Commission Approves Daklinza (Daclatasvir) For The Treatment Of Genotype 1, 3 And 4 Chronic Hepatitis C Patients With HIV Coinfection, Advanced Cirrhosis And Post-Liver Transplant Recurrence Of HCV     1/29/2016
CytoDyn Reports HIV-Patients Approaching 17 Months Of Complete Viral Suppression With PRO 140 Monotherapy     1/19/2016
Moderna, Through Valera, Its Infectious Disease Venture, Announces Initial Grant Of Up To $20 Million To Advance mRNA-Based Antibody Combination To Help Prevent HIV Infection     1/12/2016
ABIVAX Announces Positive Top-Line Clinical Phase IIa Data For Novel HIV Drug-Candidate ABX464     1/11/2016
Aelix Therapeutics Completes Series A Funding Of €11.5M ($12.7M) For Therapeutic HIV Vaccine     1/11/2016
Sangamo BioSciences (SGMO) Highlights 2016 Catalysts At The 34th Annual J.P. Morgan Healthcare Conference     1/11/2016
NIH Initiates Phase 1 Trial Of VRC01LS Anti-HIV Therapeutic Antibody Using Xencor's Xtend Fc Technology     1/7/2016
ViiV Healthcare To Progress Collaboration With Janssen To Develop The First Long-Acting, Two Drug Injectable Regimen For Treatment Of HIV-1 Infection     1/7/2016
ContraVir To Present At Biotech Showcase 2016     1/5/2016
ABIVAX Completes Recruitment Of ABX464 Phase IIa HIV Study     12/22/2015
The Medicines Patent Pool And AbbVie (ABBV) Sign Licensing Agreement To Increase Access To Crucial HIV Treatments Throughout Africa     12/18/2015
BioTime (BTX) Co-Chief Executive Officer Michael D. West, PhD To Deliver Keynote Speech At The 2015 World Stem Cell Summit     12/14/2015